Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anis Askarizadeh, Ali Badiee & Ali Khamesipour. (2020) Development of nano-carriers for Leishmania vaccine delivery. Expert Opinion on Drug Delivery 17:2, pages 167-187.
Read now
Read now
Yuqin Qiu, Lei Guo, Suohui Zhang, Bai Xu, Yunhua Gao, Yan Hu, Jun Hou, Bingke Bai, Honghui Shen & Panyong Mao. (2016) DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Delivery 23:7, pages 2391-2398.
Read now
Read now
Xindong Teng, Maopeng Tian, Jianrong Li, Songwei Tan, Xuefeng Yuan, Qi Yu, Yukai Jing, Zhiping Zhang, Tingting Yue, Lei Zhou & Xionglin Fan. (2015) Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Human Vaccines & Immunotherapeutics 11:6, pages 1456-1464.
Read now
Read now
Moayad Alhariri, Ali Azghani & Abdelwahab Omri. (2013) Liposomal antibiotics for the treatment of infectious diseases. Expert Opinion on Drug Delivery 10:11, pages 1515-1532.
Read now
Read now
Yvonne Perrie, Elisabeth Kastner, Randip Kaur, Alexander Wilkinson & Andrew J. Ingham. (2013) A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant. Human Vaccines & Immunotherapeutics 9:6, pages 1374-1381.
Read now
Read now
Chia-Hung Chen, Yu-Ling Lin, Yen-Ku Liu, Pei-Juin He, Ching-Min Lin, Yi-Han Chiu, Chang-Jer Wu, Tian-Lu Cheng, Shih-Jen Liu & Kuang-Wen Liao. (2012) Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch. International Journal of Nanomedicine 7, pages 607-621.
Read now
Read now
Articles from other publishers (81)
Selin Parmaksız, Mert Pekcan, Aykut Özkul, Ece Türkmen, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Neil Forbes, Yvonne Perrie, Constantino López-Macías & Sevda Şenel. (2023) In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles. International Journal of Pharmaceutics 648, pages 123568.
Crossref
Crossref
Chou-Yi Hsu, Ahmed Mahdi Rheima, Mustafa M. Kadhim, Nada Nadhim Ahmed, Srwa Hashim Mohammed, Fatima Hashim Abbas, Zainab Talib Abed, Zahra Muhammed Mahdi, Zainab Sabri Abbas, Safa K. Hachim, Farah K. Ali, Zaid H Mahmoud & Ehsan Kianfar. (2023) An overview of nanoparticles in drug delivery: Properties and applications. South African Journal of Chemical Engineering 46, pages 233-270.
Crossref
Crossref
Maria Vono, Beatris Mastelic-Gavillet, Elodie Mohr, Malin Östensson, Josefine Persson, Thorunn A. Olafsdottir, Sylvain Lemeille, David Pejoski, Oliver Hartley, Dennis Christensen, Peter Andersen, Arnaud M. Didierlaurent, Ali M. Harandi, Paul-Henri Lambert & Claire-Anne Siegrist. (2023) C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates. Frontiers in Immunology 14.
Crossref
Crossref
Amanda Izeli Portilho, Jessica Silva Santos, Gabriela Trzewikoswki de Lima, Gabrielle Gimenes Lima & Elizabeth De Gaspari. (2023) Study of avidity-ELISA: Comparison of chaotropic agents, incubation temperature and affinity maturation after meningococcal immunization. Journal of Immunological Methods 512, pages 113387.
Crossref
Crossref
Nathalie Garçon & Martin Friede. 2023. Plotkin's Vaccines. Plotkin's Vaccines
77
90.e4
.
Laura A. J. Feather, Vinod Nadella, Elisabeth Kastner, Yvonne Perrie, Anthony C. Hilton & Andrew Devitt. (2022) Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems. Scientific Reports 12:1.
Crossref
Crossref
Victor Araujo Correa, Amanda Izeli Portilho & Elizabeth De Gaspari. (2022) Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis. Diseases 10:3, pages 46.
Crossref
Crossref
NurEllene Mat Luwi, Suhana Ahmad, AhmadSuhaimi Nurfatihah Azlyna, Asyikin Nordin, MariaElena Sarmiento, Armando Acosta, MohdNor Azmi, Vuk Uskoković, Rohimah Mohamud & Ramlah Kadir. (2022) Liposomes as immunological adjuvants and delivery systems in the development of tuberculosis vaccine: A review. Asian Pacific Journal of Tropical Medicine 15:1, pages 7.
Crossref
Crossref
Salma B. Abdelbaky, Mayar Tarek Ibrahim, Hebatallah Samy, Menatalla Mohamed, Hebatallah Mohamed, Mahmoud Mustafa, Moustafa M. Abdelaziz, M. Laird Forrest & Islam A. Khalil. (2021) Cancer immunotherapy from biology to nanomedicine. Journal of Controlled Release 336, pages 410-432.
Crossref
Crossref
Seo Ri Wui, Ara Ko, Ji In Ryu, Eojin Sim, Soo Jeong Lim, Shin Ae Park, Kwang Sung Kim, Ha Kim, Hyewon Youn & Na Gyong Lee. (2021) The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes. Pharmaceutics 13:3, pages 390.
Crossref
Crossref
Marta Sisteré-Oró, Gabriel K. Pedersen, Lorena Córdoba, Sergi López-Serrano, Dennis Christensen & Ayub Darji. (2020) Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate. Veterinary Research 51:1.
Crossref
Crossref
Helena Strand Clemmensen, Niels Peter Hell Knudsen, Rolf Billeskov, Ida Rosenkrands, Gregers Jungersen, Claus Aagaard, Peter Andersen & Rasmus Mortensen. (2020) Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection. Frontiers in Immunology 11.
Crossref
Crossref
Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner & Yvonne Perrie. (2020) Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines. Vaccines 8:2, pages 212.
Crossref
Crossref
Craig P. McEntee, Hannah B.T. Moran, Natalia Muñoz-Wolf, Alex M. Liddicoat, Elizabeth C. Carroll, Jeanette Erbo-Wern, Ivan S. Coulter, Peter Andersen, Frank Follmann & Ed C. Lavelle. (2020) Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming. Vaccine 38:3, pages 635-643.
Crossref
Crossref
Jana Kubackova, Jarmila Zbytovska & Ondrej Holas. (2020) Nanomaterials for direct and indirect immunomodulation: A review of applications. European Journal of Pharmaceutical Sciences 142, pages 105139.
Crossref
Crossref
Yasunobu Miyake & Sho Yamasaki. 2020. Lectin in Host Defense Against Microbial Infections. Lectin in Host Defense Against Microbial Infections
31
56
.
Xiyu Ke, Gregory P. Howard, Haoyu Tang, Bei Cheng, May Tun Saung, José L. Santos & Hai-Quan Mao. (2019) Physical and chemical profiles of nanoparticles for lymphatic targeting. Advanced Drug Delivery Reviews 151-152, pages 72-93.
Crossref
Crossref
Xiaoyi Sun, Linghui Zeng & Yongzhuo Huang. (2019) Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination. The Journal of Gene Medicine 21:7.
Crossref
Crossref
Manaf AlMatar, Essam A. Makky, Husam AlMandeal, Emel Eker, Begüm Kayar, Işıl Var & Fatih Köksal. (2019) Does the Development of Vaccines Advance Solutions for Tuberculosis?. Current Molecular Pharmacology 12:2, pages 83-104.
Crossref
Crossref
Dennis Christensen, Lasse Bøllehuus Hansen, Romain Leboux, Wim Jiskoot, Jan Pravsgaard Christensen, Peter Andersen & Jes Dietrich. (2019) A Liposome-Based Adjuvant Containing Two Delivery Systems with the Ability to Induce Mucosal Immunoglobulin A Following a Parenteral Immunization. ACS Nano.
Crossref
Crossref
Qi Liu, Xiaoming Chen, Jilei Jia, Ting Lu, Tingyuan Yang & Lianyan Wang. (2018) Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen. Molecular Pharmaceutics 15:11, pages 5227-5235.
Crossref
Crossref
Letícia Rodrigues, Konstantinos N. Raftopoulos, Signe Tandrup Schmidt, Fabian Schneider, Hendrik Dietz, Thomas Rades, Henrik Franzyk, Anders Elm Pedersen, Christine M. Papadakis, Dennis Christensen, Gerhard Winter, Camilla Foged & Madlen Hubert. (2018) Immune responses induced by nano-self-assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the Chlamydia trachomatis major outer membrane protein. Journal of Controlled Release 285, pages 12-22.
Crossref
Crossref
Maria Vono, Christiane Sigrid Eberhardt, Elodie Mohr, Floriane Auderset, Dennis Christensen, Mirco Schmolke, Rhea Coler, Andreas Meinke, Peter Andersen, Paul-Henri Lambert, Beatris Mastelic-Gavillet & Claire-Anne Siegrist. (2018) Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan. Frontiers in Immunology 9.
Crossref
Crossref
Luis Martinez-Gil, Peter H. Goff & Gene S. Tan. 2018.
1
37
.
Nathalie Garçon & Martin Friede. 2018. Plotkin's Vaccines. Plotkin's Vaccines
61
74.e4
.
Farzad Khademi, Ramezan Ali Taheri, Amir Abbas Momtazi-Borojeni, Gholamreza Farnoosh, Thomas P. Johnston & Amirhossein Sahebkar. 2018. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
47
69
.
Luis O. De Serrano & David J. Burkhart. (2017) Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines. Journal of Nanobiotechnology 15:1.
Crossref
Crossref
Kasper Rømer Villumsen, Erling Olaf Koppang, Dennis Christensen & Anders Miki Bojesen. (2017) Alternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effects. Scientific Reports 7:1.
Crossref
Crossref
Nikolay Dimov, Elisabeth Kastner, Maryam Hussain, Yvonne Perrie & Nicolas Szita. (2017) Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system. Scientific Reports 7:1.
Crossref
Crossref
Monzer Fanun. 2017. Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
301
311
.
Hayley K. Charlton Hume & Linda H.L. Lua. (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35:35, pages 4480-4485.
Crossref
Crossref
Sae-Hae Kim & Yong-Suk Jang. (2017) The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants. Clinical and Experimental Vaccine Research 6:1, pages 15.
Crossref
Crossref
D. Christensen. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
333
345
.
Zhenguang Liu, Jie Xing, Sisi Zheng, Ruonan Bo, Li Luo, Yee Huang, Yale Niu, Zhihua Li, Deyun Wang, Yuanliang Hu, Jiaguo Liu & Yi Wu. (2016) Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydrate Polymers 142, pages 141-148.
Crossref
Crossref
Xun Liu, Zejiao Da, Yue Wang, Hongxia Niu, Ruiying Li, Hongjuan Yu, Shanshan He, Ming Guo, Yong Wang, Yanping Luo, Xingming Ma & Bingdong Zhu. (2016) A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Vaccine 34:11, pages 1370-1378.
Crossref
Crossref
Peter M. H. Heegaard, Yongxiang Fang & Gregers Jungersen. 2016. Vaccine Technologies for Veterinary Viral Diseases. Vaccine Technologies for Veterinary Viral Diseases
63
82
.
Monzer Fanun. 2015. Handbook of Encapsulation and Controlled Release. Handbook of Encapsulation and Controlled Release
1111
1126
.
Peter C. Soema, Geert-Jan Willems, Wim Jiskoot, Jean-Pierre Amorij & Gideon F. Kersten. (2015) Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 427-435.
Crossref
Crossref
Stephanie Kallert, Sebastian F. Zenk, Paul Walther, Mark Grieshober, Tanja Weil & Steffen Stenger. (2015) Liposomal delivery of lipoarabinomannan triggers Mycobacterium tuberculosis specific T-cells. Tuberculosis 95:4, pages 452-462.
Crossref
Crossref
Catherine A. Fromen, Gregory R. Robbins, Tammy W. Shen, Marc P. Kai, Jenny P. Y. Ting & Joseph M. DeSimone. (2014) Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization. Proceedings of the National Academy of Sciences 112:2, pages 488-493.
Crossref
Crossref
Yuqin qiu, Lei Guo, Panyong Mao & Yunhua Gao. (2015) Dissolving Microneedle Arrays for Intradermal Immunization of Hepatitis B Virus DNA Vaccine. Procedia in Vaccinology 9, pages 24-30.
Crossref
Crossref
Ruchi R Shah, Derek T O'Hagan, Mansoor M Amiji & Luis A Brito. (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9:17, pages 2671-2681.
Crossref
Crossref
Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew Graves, Birgit Thierry-Carstensen, Lars V. Andreasen, Morten Ruhwald, Adriëtte W. de Visser, Else Marie Agger, Tom H.M. Ottenhoff, Ingrid Kromann & Peter Andersen. (2014) A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine 32:52, pages 7098-7107.
Crossref
Crossref
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Crossref
Sae-Hae Kim & Yong-Suk Jang. (2014) Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Experimental & Molecular Medicine 46:3, pages e85-e85.
Crossref
Crossref
Randip Kaur, Malou Henriksen-Lacey, Jitinder Wilkhu, Andrew Devitt, Dennis Christensen & Yvonne Perrie. (2013) Effect of Incorporating Cholesterol into DDA:TDB Liposomal Adjuvants on Bilayer Properties, Biodistribution, and Immune Responses. Molecular Pharmaceutics 11:1, pages 197-207.
Crossref
Crossref
Maria de los Angeles García, Reinier Borrero, Maria E. Lanio, Yanely Tirado, Nadine Alvarez, Alina Puig, Alicia Aguilar, Liem Canet, Dulce Mata Espinoza, Jorge Barrios Payán, María Elena Sarmiento, Rogelio Hernández-Pando, Mohd-Nor Norazmi & Armando Acosta. (2014)
Protective Effect of a Lipid-Based Preparation from
Mycobacterium smegmatis
in a Murine Model of Progressive Pulmonary Tuberculosis
. BioMed Research International 2014, pages 1-6.
Crossref
Crossref
Victor Raúl Gómez RománKristoffer Jarlov JensenSanne Skov JensenChristian Leo-HansenSanne JespersenDavid da Silva TéCandida Medina RodriguesChristoph Mikkel JanitzekLasse VinnerTerese Lea KatzensteinPeter AndersenIngrid KromannLars Vibe AndreasenIngrid KarlssonAnders Fomsgaard. (2013) Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau. AIDS Research and Human Retroviruses 29:11, pages 1504-1512.
Crossref
Crossref
Mette Hamborg, Ryan Kramer, Carole E. Schanté, Else Marie Agger, Dennis Christensen, Lene Jorgensen, Camilla Foged & C. Russell Middaugh. (2013) The Physical Stability of the Recombinant Tuberculosis Fusion Antigens H1 and H56. Journal of Pharmaceutical Sciences 102:10, pages 3567-3578.
Crossref
Crossref
Steven C. Derrick, Idalia M. Yabe, Amy Yang, Kristopher Kolibab, Brynn Hollingsworth, Sherry L. Kurtz & Sheldon Morris. (2013) Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens. Vaccine 31:41, pages 4641-4646.
Crossref
Crossref
Ofer Levy, Stanislas Goriely & Tobias R. Kollmann. (2013) Immune response to vaccine adjuvants during the first year of life. Vaccine 31:21, pages 2500-2505.
Crossref
Crossref
Yasunobu Miyake, Kenji Toyonaga, Daiki Mori, Shigeru Kakuta, Yoshihiko Hoshino, Akiko Oyamada, Hisakata Yamada, Ken-ichiro Ono, Mikita Suyama, Yoichiro Iwakura, Yasunobu Yoshikai & Sho Yamasaki. (2013) C-type Lectin MCL Is an FcRγ-Coupled Receptor that Mediates the Adjuvanticity of Mycobacterial Cord Factor. Immunity 38:5, pages 1050-1062.
Crossref
Crossref
Lei Guo, Jianmin Chen, Yuqin Qiu, Suohui Zhang, Bai Xu & Yunhua Gao. (2013) Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. International Journal of Pharmaceutics 447:1-2, pages 22-30.
Crossref
Crossref
Ingrid Karlsson, Lea Brandt, Lasse Vinner, Ingrid Kromann, Lars Vibe Andreasen, Peter Andersen, Jan Gerstoft, Gitte Kronborg & Anders Fomsgaard. (2013) Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection. Clinical Immunology 146:2, pages 120-130.
Crossref
Crossref
Babak Jalilian, Stig Hill Christiansen, Halldór Bjarki Einarsson, Mehdi Rasoli Pirozyan, Eskild Petersen & Thomas Vorup-Jensen. (2013) Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?. Molecular and Cellular Therapies 1:1, pages 2.
Crossref
Crossref
Nathalie. Garçon, Stanley. Hem & Martin. Friede. 2013. Vaccines. Vaccines
58
70
.
Yvonne Perrie, Randip Kaur & Malou Henriksen-Lacey. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
465
491
.
Randip Kaur, Vincent W. Bramwell, Daniel J. Kirby & Yvonne Perrie. (2012) Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response. Journal of Controlled Release 164:3, pages 331-337.
Crossref
Crossref
Nils Lycke. (2012) Recent progress in mucosal vaccine development: potential and limitations. Nature Reviews Immunology 12:8, pages 592-605.
Crossref
Crossref
David A Christian & Christopher A Hunter. (2012) Particle-mediated delivery of cytokines for immunotherapy. Immunotherapy 4:4, pages 425-441.
Crossref
Crossref
Hong Yu, Karuna P. Karunakaran, Xiaozhou Jiang, Caixia Shen, Peter Andersen & Robert C. Brunham. (2012) Chlamydia muridarum T Cell Antigens and Adjuvants That Induce Protective Immunity in Mice. Infection and Immunity 80:4, pages 1510-1518.
Crossref
Crossref
Steven C. Derrick, Dee Dao, Amy Yang, Kris Kolibab, William R. Jacobs & Sheldon L. Morris. (2012) Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis. PLoS ONE 7:3, pages e32959.
Crossref
Crossref
Douglas S. Watson, Aaron N. Endsley & Leaf Huang. (2012) Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:13, pages 2256-2272.
Crossref
Crossref
Randip Kaur, Vincent W. Bramwell, Daniel J. Kirby & Yvonne Perrie. (2012) Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses. Journal of Controlled Release 158:1, pages 72-77.
Crossref
Crossref
Gilles Bioley, Philippe Bussat, Anne Lassus, Michel Schneider, Jacques Terrettaz & Blaise Corthésy. (2012) The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells. Biomaterials 33:1, pages 333-342.
Crossref
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology
135
178
.
Yong Taik Lim, Sang-Mu Shim, Young-Woock Noh, Kyung-Soon Lee, Doo-Yeol Choi, Hiroshi Uyama, Hee Ho Bae, Ji Hyun Kim, Kwan Soo Hong, Moon-Hee Sung & Haryoung Poo. (2011) Bioderived Polyelectrolyte Nanogels for Robust Antigen Loading and Vaccine Adjuvant Effects. Small 7:23, pages 3281-3286.
Crossref
Crossref
Qing Wang, Yuly A. Jaimes‐Lizcano, Louise B. Lawson, Vijay T. John & Kyriakos D. Papadopoulos. (2011) Improved dermal delivery of FITC–BSA using a combination of passive and active methods. Journal of Pharmaceutical Sciences 100:11, pages 4804-4814.
Crossref
Crossref
Ciara Kelly, Caroline Jefferies & Sally-Ann Cryan. (2011) Targeted Liposomal Drug Delivery to Monocytes and Macrophages. Journal of Drug Delivery 2011, pages 1-11.
Crossref
Crossref
Marina Pinheiro, Marlene Lúcio, José LFC Lima & Salette Reis. (2011) Liposomes as drug delivery systems for the treatment of TB. Nanomedicine 6:8, pages 1413-1428.
Crossref
Crossref
Anders Fomsgaard, Ingrid Karlsson, Gregers Gram, Christian Schou, Sheila Tang, Peter Bang, Ingrid Kromann, Peter Andersen & Lars Vibe Andreasen. (2011) Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01. Vaccine 29:40, pages 7067-7074.
Crossref
Crossref
Bram Slütter, Suzanne M. Bal, Zhi Ding, Wim Jiskoot & Joke A. Bouwstra. (2011) Adjuvant effect of cationic liposomes and CpG depends on administration route. Journal of Controlled Release 154:2, pages 123-130.
Crossref
Crossref
Nijaporn Yanasarn, Brian R. Sloat & Zhengrong Cui. (2011) Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens. Molecular Pharmaceutics 8:4, pages 1174-1185.
Crossref
Crossref
S. I. Tat’kov, E. V. Deineko & D. P. Furman. (2011) Prospects for designing new generation anti-tuberculosis vaccines. Russian Journal of Genetics: Applied Research 1:4.
Crossref
Crossref
Pernille Nordly, Fabrice Rose, Dennis Christensen, Hanne Mørck Nielsen, Peter Andersen, Else Marie Agger & Camilla Foged. (2011) Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method. Journal of Controlled Release 150:3, pages 307-317.
Crossref
Crossref
Suzanne M. Bal, Sander Hortensius, Zhi Ding, Wim Jiskoot & Joke A. Bouwstra. (2011) Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination. Vaccine 29:5, pages 1045-1052.
Crossref
Crossref
Pernille Nordly, Karen Smith Korsholm, Esra Alici Pedersen, Tayba Sajid Khilji, Henrik Franzyk, Lene Jorgensen, Hanne Mørck Nielsen, Else Marie Agger & Camilla Foged. (2011) Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo. European Journal of Pharmaceutics and Biopharmaceutics 77:1, pages 89-98.
Crossref
Crossref
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. Journal of Controlled Release 145:2, pages 102-108.
Crossref
Crossref
Jiafen Hu, Nancy Cladel, Karla Balogh & Neil Christensen. (2010) Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits. Vaccine 28:21, pages 3706-3713.
Crossref
Crossref
Gregory Gregoriadis & Yvonne Perrie. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Marija Brgles, Lidija Habjanec, Beata Halassy & Jelka Tomašić. (2009) Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. Vaccine 27:40, pages 5435-5442.
Crossref
Crossref